ArticleFrontiers in pharmacology2024

RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.

Uwe Grether et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.